US Stock MarketDetailed Quotes

BPTSY BIOPHYTIS SPON ADR EACH REP 10 ORD(POST SPLIT)

Watchlist
  • 3.050
  • 0.0000.00%
15min DelayClose Dec 18 16:00 ET
2.24MMarket Cap-0.07P/E (TTM)

About BIOPHYTIS SPON ADR EACH REP 10 ORD(POST SPLIT) Company

Biophytis SA operates as a clinical-stage biotechnology company. It specializes in the development of therapeutics that are aimed at slowing the degenerative processes associated with aging, including severe respiratory failure in patients suffering from COVID-19. Its products include Sarconeos (BIO101), which is used to treat sarcopenic obesity and Macuneos (BIO201), which is used to treat dry age-related macular degeneration (AMD). The company was founded by Stanislas Veillet and René Lafont on September 27, 2006 and is headquartered in Paris, France.

Company Profile

SymbolBPTSY
Company NameBIOPHYTIS SPON ADR EACH REP 10 ORD(POST SPLIT)
Listing DateFeb 10, 2021
Founded2006
CEOMr. Stanislas Veillet
MarketPink Market
Employees24
Fiscal Year Ends12-31
AddressSorbonne Université,Batiment A 4 ème étage,4 place Jussieu
CityParis
ProvinceIle-de-France
CountryFrance
Zip Code75005
Phone33-1-44-27-23-00
Websitehttp://www.biophytis.com

Company Executives

  • Name
  • Position
  • Salary
  • Stanislas Veillet
  • Chairman of the Board and Chief Executive Officer
  • 25.00K
  • Rob Van Maanen
  • Chief Medical Officer
  • --
  • Dr. Pierre J. Dilda
  • Chief Scientific Officer
  • --
  • Nicolas Fellmann
  • Chief Financial Officer
  • --
  • Chiara Baccelli
  • Chief Pharmaceutical Operations Officer & Quality Assurance Director
  • --
  • Waly Dioh
  • Chief Clinical Operations Officer
  • --
  • Edouard Bieth
  • Chief Business Officer
  • --
  • Jean Mariani
  • Director
  • 25.00K
  • Claude Allary
  • Independent Director
  • 25.00K
  • Nadine Coulm
  • Independent Director
  • 25.00K
Heat List
US
Overall
Symbol
Price
% Chg

No Data